VitalWorks revenues drop

Article

IT provider VitalWorks, which last year acquired PACS vendor Amicas, reported a drop in revenues for the fourth quarter ended Dec. 31, compared with both the immediately preceding quarter and the same period a year earlier. The company tallied $26.7

IT provider VitalWorks, which last year acquired PACS vendor Amicas, reported a drop in revenues for the fourth quarter ended Dec. 31, compared with both the immediately preceding quarter and the same period a year earlier. The company tallied $26.7 million, compared with $28.1 million in the preceding quarter (end Sept. 30) and $29 million for the quarter ending Dec. 31, 2002. VitalWorks had a net loss of $2 million for 4Q 2003, compared with net income of $4.1 million for the corresponding 2002 period. On the bright side, deferred revenues rose to $11.8 million as of Dec. 31 from $7.9 million on Sept. 30. Company executives predicted that PACS will drive growth in radiology IT for the next several years, and that the combination of Amicas' PACS and its own radiology products will provide an advantage in this market.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.